Trial intelligence / Profile preview

Intrathecal levobupivacaine MLAD in cesarean section

2008-006235-12Phase 4Completed

Sponsor
Sant'Orsola-Malpighi University Hospital
Start
Jul 2009
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of levobupivacaine and sufentanil in labor pain and caesarean delivery (C-section), sponsored by Sant'Orsola-Malpighi University Hospital. Primary endpoint: Minimum local anesthetic dose of intrathecal levobupivacaine. Started Jul 2009; status: completed.

02

Drugs

levobupivacainesufentanil
03

Conditions

labor paincaesarean delivery (C-section)

Beyond the preview

Go deeper on 2008-006235-12.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-006235-12.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call